HealthLabs.com Direct-to-Consumer Lab Testing vs SiPhox Health At-Home Biomarker Test
Specs, prices, editor verdict, and who should buy which - compared side-by-side.
HealthLabs.com Direct-to-Consumer Lab Testing (mid, $24–$459) vs SiPhox Health At-Home Biomarker Test (entry, $99–$189) - different tools for different jobs (see the per-product details below).
Compared on 1 shared spec · same category (diagnostic).
These are close picks. Both score in the same range. The right call depends on buyer profile - read the per-buyer recommendations below.
Side-by-side specs
| Spec | HealthLabs.com Direct-to-Consumer Lab Testing | SiPhox Health At-Home Biomarker Test |
|---|---|---|
| price | $24–$459 | $99–$189 |
| hsa fsa | HSA/FSA eligible | Yes - HSA/FSA eligible |
HealthLabs.com Direct-to-Consumer Lab Testing also publishes: labNetwork, orderingTime, resultsTime, insurance, panelCoverage
SiPhox Health At-Home Biomarker Test also publishes: testType, biomarkers, turnaround, insights, pricing, firstKitShipping
Who should buy which
Buyers who know which specific tests they need, want them fast, and are comfortable interpreting raw lab values. Patients running protocols their primary care doctor won't order for.
You want trend analysis and AI insights across multiple panels (go Function Health or Mito Health). Or you need clinician review of abnormal results.
Buyers who want frequent, low-friction biomarker tracking without lab visits or needles, especially anyone testing quarterly to watch trends rather than once a year. HSA/FSA users get a meaningful pre-tax discount.
You want the single broadest one-time panel (Function 110+ or Mito 100+ markers with physician review), or you need an active prescribing relationship for hormones or GLP-1s - this is testing and insight only.